Jun 20, 2025 09:20AM Moleculin Biotech (MBRX) Prices 16.08M Share Offering at $0.37/sh

Jun 20, 2025 09:20AM Moleculin Announces $5.9 Million Public Offering

Feb 25, 2025 12:35PM Moleculin Biotech (MBRX) Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At The Market Under Nasdaq Rules

Feb 25, 2025 12:35PM Moleculin Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At The Market Under Nasdaq Rules

Feb 13, 2025 01:07PM Moleculin Biotech (MBRX) Announces Exercise of Warrants for $5.8M Gross Proceeds

Feb 13, 2025 01:05PM Moleculin Announces Exercise of Warrants for $5.8 Million Gross Proceeds

Aug 19, 2024 04:05PM Moleculin Announces Closing of up to $16.5 Million Public Offering

Dec 1, 2021 10:12AM Roth Capital Reiterates Buy Rating on Moleculin Biotech (MBRX) as FDA Clears Phase 1 Study of WP1122

Apr 14, 2021 09:23AM Pre-Open Stock Movers 04/14: (GALT) (MBRX) (IDEX) Higher; (BBBY) (MFH) (DISCK) Lower (more...)

Feb 10, 2021 04:15PM Moleculin Announces Full Exercise of Over-Allotment Option

Feb 3, 2021 08:32AM Moleculin Biotech (MBRX) Prices 14.27M Share Common Offering at $4.75/Sh

Feb 3, 2021 08:30AM Moleculin Announces Pricing Of $67.8 Million Underwritten Public Offering

Feb 1, 2021 10:30AM Moleculin Biotech (MBRX) PT Raised to $29 at Roth Capital, Adjusting PT After 1 To 6 Stock Split

Nov 13, 2020 07:30AM Moleculin Biotech, Inc. Reports Financial Results for the Quarter Ended September 30, 2020

Oct 27, 2020 07:30AM Moleculin to Participate in Panel at ROTH Capital's "COVID-19 Therapeutics in Development" Healthcare Event

Feb 6, 2020 09:03AM UPDATE: Moleculin Biotech (MBRX) Announces $6M Registered Direct Offering at $0.80/Unit

Feb 6, 2020 09:00AM Moleculin Announces $6.0 Million Registered Direct Offering

May 24, 2019 05:04AM Roth Capital Transfers Coverage on Moleculin Biotech (MBRX) at Buy

Apr 23, 2019 08:42AM Moleculin Biotech (MBRX) Prices 9.375M Unit Offering at $1.60/Unit

Apr 23, 2019 08:40AM Moleculin Announces $15.0 Million Registered Direct Offering

Mar 27, 2019 09:06AM Moleculin Biotech (MBRX) Prices Underwritten Public Offering of Common Stock and Warrants

Mar 27, 2019 09:05AM Moleculin Announces Pricing Of Underwritten Public Offering

Feb 20, 2019 07:30AM Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development

Feb 20, 2019 07:30AM Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development

Jun 21, 2018 07:32AM Moleculin Biotech (MBRX) Reports $2.3 Million Registered Direct Offering Priced At-the-Market

Jun 21, 2018 07:30AM Moleculin Announces $2.3 Million Registered Direct Offering Priced At-the-Market

Jun 21, 2018 07:30AM Moleculin Announces $2.3 Million Registered Direct Offering Priced At-the-Market

Mar 6, 2018 08:30AM Moleculin to Present at the 30th Annual ROTH Conference Tuesday, March 13, 2018

Feb 16, 2018 08:30AM Moleculin Biotech (MBRX) Prices $9 Million Registered Direct Offering

Feb 16, 2018 08:28AM Moleculin Announces Pricing of $9 Million Registered Direct Offering

Dec 20, 2017 07:14AM Roth Capital Starts Moleculin Biotech (MBRX) at Buy, 'liposomal anthracycline Annamycin sits in a goldilocks zone'

May 15, 2017 07:30AM Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2017

Apr 3, 2017 07:30AM Moleculin Biotech, Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Mar 10, 2017 07:30AM Moleculin to Present at the 29th Annual Roth Capital Conference

Feb 9, 2017 09:14AM Moleculin Biotech (MBRX) Prices 3.71M Unit Offering at $1.35

Feb 9, 2017 09:09AM Moleculin Announces Pricing of $5 Million Underwritten Public Offering